Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Epilepsy
Interventions
DRUG

Levetiracetam

"Intravenous 100 mg/mL, twice a day, maximum of 4 days~Subjects on oral levetiracetam at study entry receive the same intravenous (IV) dosage (mg-for-mg) to their oral dose.~Dosage for subjects not on levetiracetam at study entry was based on weight: if \<50 kg, the dose was 20 mg/kg/day (10 mg/kg/day twice daily); if weight ≥ 50 kg, the dose of levetiracetam intravenous (LEV IV) was 1000 mg/day (500 mg twice daily)."

Trial Locations (25)

Unknown

La Jolla

Boston

Chesterfield

Buffalo

Philadelphia

Nashville

Fort Worth

Richmond

Milwaukee

Brussels

Ghent

Leuven

Amiens

Lille

Paris

Heidelberg

Kehl

Torreón

Puebla City

Aguascalientes

Guadalajara

Mexico City

Puebla City

Ankara

Izmir

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY